|
Volumn 61, Issue 1, 2005, Pages 70-75
|
Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: A clinical Phase II trial
|
Author keywords
Chemotherapy; Clinical trial; Hyperfractionated accelerated radiation therapy; Limited stage small cell lung cancer
|
Indexed keywords
COMPUTERIZED TOMOGRAPHY;
FAILURE ANALYSIS;
PATIENT MONITORING;
PULMONARY DISEASES;
RADIATION;
RADIOTHERAPY;
TUMORS;
ETOPSIDE (EP);
HYPERFRACTIONATED ACCELERATED RADIATION THERAPY (HART);
LIMITED-STAGE SMALL-CELL LUNG CANCER (LSCLC);
CHEMOTHERAPY;
CISPLATIN;
CORTICOSTEROID;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
ADULT;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
ESOPHAGITIS;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL TOXICITY;
HUMAN;
LEUKOPENIA;
LUNG FIBROSIS;
LUNG SMALL CELL CANCER;
LUNG TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
PHASE 2 CLINICAL TRIAL;
PNEUMONIA;
PRIORITY JOURNAL;
RADIATION DOSE FRACTIONATION;
RADIATION INJURY;
SURVIVAL RATE;
SURVIVAL TIME;
THROMBOCYTOPENIA;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRAIN NEOPLASMS;
CARCINOMA, SMALL CELL;
CISPLATIN;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
ETOPOSIDE;
FEASIBILITY STUDIES;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
RADIOTHERAPY;
RADIOTHERAPY DOSAGE;
|
EID: 11144319428
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ijrobp.2004.04.058 Document Type: Article |
Times cited : (18)
|
References (14)
|